Table 1.

Th1 but not Th2 lymphokine secretion is impaired by Lptn

Stimulus IL-2 (day 1) IFN-γ (day 3) IL-4 (day 3)
CD3  0.44 (0.04)  7.03 (2.30) 0.75 (0.45)  
CD3 + Lptn  0.09 (0.04) 3.77 (1.99)  0.75 (0.49) 
CD3 + Lptn + anti-Lptn  0.39 (0.09)  7.65 (2.17) 0.74 (0.44)  
CD3 + RANTES  0.44 (0.19)  8.43 (0.81) 0.67 (0.41)  
CD3 + RANTES + anti-RANTES  0.38 (0.08) 7.43 (1.20)  0.63 (0.36)  
CD3 + CD28  2.76 (1.55) 17.2 (7.85)  0.45 (0.23) 
Stimulus IL-2 (day 1) IFN-γ (day 3) IL-4 (day 3)
CD3  0.44 (0.04)  7.03 (2.30) 0.75 (0.45)  
CD3 + Lptn  0.09 (0.04) 3.77 (1.99)  0.75 (0.49) 
CD3 + Lptn + anti-Lptn  0.39 (0.09)  7.65 (2.17) 0.74 (0.44)  
CD3 + RANTES  0.44 (0.19)  8.43 (0.81) 0.67 (0.41)  
CD3 + RANTES + anti-RANTES  0.38 (0.08) 7.43 (1.20)  0.63 (0.36)  
CD3 + CD28  2.76 (1.55) 17.2 (7.85)  0.45 (0.23) 

The CD4+ T cells were activated with the indicated stimuli, as described in “Materials and methods.” Supernatants were collected each day from days 1 to 3 and were analyzed for lymphokine concentrations by ELISA. Concentration mean values (ng/mL) are followed by the SD in parentheses. In our hands, only stimulation with PMA and ionomycin gave 2 times higher IL-4 secreted levels than CD3 stimulation, alone or combined with CD28. For each lymphokine, data are representative of 4 independent experiments, except for conditions using RANTES, where 2 experiments were done.

or Create an Account

Close Modal
Close Modal